Delcath Systems - DCTH Quarterly Revenue Growth

Brandmark of delcath.com (DCTH)

Delcath Systems, Inc. (DCTH) is based in the US, developing unique Chemosat systems for targeted liver therapy. The company's quarterly revenue growth, as reported by the GURU.Markets system, confirms the success of its strategy, with the 70.40 level serving as a critical benchmark. The issuer's competitiveness is guaranteed by stringent patents, while the current development vector relies on the independent deployment of commercial networks within medical centers.

DCTH (Delcath Corp) Quarterly Revenue Growth history from 07/04/2022 to 11/20/2026

Analytical breakdowns for Delcath (DCTH)

- current quotes and average value forecast:
General company analysis:DCTH - delcath.com
Manufactured products of Delcath Systems Inc

The operational success of Delcath Systems, Inc. (DCTH) is directly reflected in the revenue growth rates between consecutive quarters. This metric measures the percentage deviation of current sales from the previous period, allowing the quarterly sales growth chart to provide timely signals of business stagnation or acceleration. For Delcath Systems, Inc. (DCTH), this indicator serves as a benchmark for the effective implementation of the HEPZATO KIT system across oncology centers. A positive trend confirms the expansion of insurance coverage and the successful commercialization of the product.

Competitors of Delcath Systems, Inc.

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase YMAB|AURA - Revenue Growth QoQ|candeltx.com - Sales Change QoQ|ARAY: Quarterly Revenue Growth|Revenue Dynamics QoQ SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Quarterly Revenue Growth|Quarterly Sales Growth Citius Oncology Inc. (CTOR)|Revenue Growth QoQ TuHURA (HURA)|TARA - Quarterly Revenue Growth Rate|Quarterly Revenue Growth FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Quarterly Revenue Growth Rate|TScan - Quarterly Revenue Growth|Champions Oncology, Inc. (CSBR) - Quarterly Sales Growth|XBIT (XBiotech Inc.) - Quarterly Sales Growth|CEL-SCI Corporation (CVM) - Quarterly Revenue Growth|Revenue Growth QoQ OS Therapies|RADX: Quarterly Revenue Increase|Revenue Growth QoQ artivabio.com (ARTV)|Quarterly Sales Growth Rate Adlai Nortye|Quarterly Revenue Growth VERU (Veru Corporation)|Sales Change QoQ TPST (Tempest Tx)|XLO: Quarterly Sales Growth|renovarobio.com (RENB) - Quarterly Sales Growth|Mural Bio (MURA) - Revenue Growth QoQ|Kairos Pharma Inc (KAPA) - Quarterly Revenue Growth|Quarterly Sales Growth OKUR|CytoMed Therapeutics (GDTC) - Quarterly Sales Growth Rate|Quarterly Sales Growth CRIS (Curis Inc.)|Quarterly Revenue Growth Apollomics Inc. (APLM)|Revenue Growth QoQ Tharimmune Corp THAR|Advanced Biomed Corp - Revenue Growth QoQ|GNPX: Quarterly Sales Growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly Sales Growth|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)